Novo Nordisk to sell Wegovy in bigger European markets -- Bloomberg

Feb. 07, 2023 6:18 PM ETNovo Nordisk A/S (NVO)By: Jonathan Block, SA News Editor2 Comments

Novo Nordisk headquarters in Silicon Valley

Sundry Photography

  • Novo Nordisk (NVO) has resolved production issues that impacted availability of its hugely popular weight loss drug Wegovy (semaglutide) and now says it will launch the drug in larger European markets later this year.
  • Speaking on Bloomberg

Recommended For You

Comments (2)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.